Related Experiment Video
Updated: Jun 16, 2026
08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Inflammatory Bowel Diseases: the genetic revolution
1Hopital Robert Debré, Service de gastroentérologie et nutrition pédiatriques, 48, boulevard Sérurier, 75019 Paris, France.
Gastroenterologie Clinique Et Biologique
|February 2, 2010
Summary
Genetic research reveals key susceptibility genes for Inflammatory Bowel Diseases (IBD). Genome-wide scans identified genes linked to Crohn disease, highlighting innate immunity and autophagy, and ulcerative colitis, implicating TH-17 differentiation.
Area of Science:
- Genetics
- Immunology
- Gastroenterology
Background:
- Inflammatory Bowel Diseases (IBD) are complex genetic disorders.
- Previous functional candidate gene approaches yielded limited success.
- Genome-wide scans have revolutionized the identification of IBD susceptibility genes.
Purpose of the Study:
- To summarize the current understanding of genetic factors in IBD.
- To highlight newly identified susceptibility genes for Crohn disease and ulcerative colitis.
- To emphasize the biological pathways implicated in IBD pathogenesis.
Main Methods:
- Genome-wide association studies (GWAS) were employed to identify susceptibility loci.
- Analysis of genetic data to pinpoint specific genes associated with IBD.
- Review of existing literature on IBD genetics.
Main Results:
- Numerous susceptibility genes identified for Crohn disease, including NOD2, IL23R, ATG16L1, IRGM, TNFSF15, PTGER4, PTPN2, PTPN22, and NKX2-3.
- The gene ECM1 has been identified as a susceptibility gene for ulcerative colitis.
- These findings underscore the roles of innate immunity and autophagy in Crohn disease, and TH-17 cell differentiation in ulcerative colitis and other inflammatory conditions.
Conclusions:
- Genetic studies have significantly advanced the understanding of IBD.
- New susceptibility genes provide crucial insights into disease mechanisms.
- Further research is needed to elucidate the biological functions of these identified genes in IBD.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...